| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Central Institute of Mental Health (B.W.-H., F.H., A.K., M.D., M.C., F.L., I.H.), Mannheim; and Department of Psychiatry, Free University of Berlin (I.H.), University Hospital Benjamin Franklin, Berlin, Germany.
Address reprint requests to: Isabella Heuser, Department of Psychiatry, Free University of Berlin, University Hospital Benjamin Franklin, Eschenallee 3, 14050 Berlin, Germany. Email: isabella.heuser@ medizin.fu-berlin.de
OBJECTIVE: Similar to patients with a metabolic syndrome, patients with major depression are at increased risk of developing cardiovascular disorders. Interestingly, both disorders share a specific endocrine syndrome that promotes the accumulation of visceral fat, which again is considered a marker of increased cardiovascular morbidity and mortality.
METHODS: Intra-abdominal fat was measured in 22 postmenopausal depressed women and 23 age-matched healthy women by computer tomography at the level of lumbar vertebrae 1 (L1) and 4 (L4). Saliva was taken in patients and control subjects at 08:00 hours over a period of 7 drug-free days for the measurement of free cortisol. In patients only we performed an oral glucose tolerance test.
RESULTS: Compared with control subjects, depressed patients with elevated free cortisol concentrations showed similar visceral fat depots at L1 (113.0 ± 41.6 vs. 94.3 ± 53.2 cm2). Hypercortisolemic depressed patients also showed greater fat depots in this area (74.5 ± 55.5 cm2, p = .04) than the normocortisolemic patients. However, a comparison of all patients with control subjects revealed no difference in fat accumulation at either L1 or L4. Finally, glucose concentrations during the glucose tolerance test were higher in hypercortisolemic than in normocortisolemic patients, whereas their insulin levels showed only a tendency toward being increased.
CONCLUSIONS: Hypercortisolemic depressed patients suffer from resistance to insulin and increased visceral fat. The fact that hypercortisolemia reverses depression-related fat loss, particularly in the visceral area, might partially explain why major depression can be considered a risk factor for cardiovascular disorders.
Key Words: major depression, hypercortisolemia, visceral fat, insulin resistance.
Abbreviations: BMI = body mass index;; HAM-D = Hamilton Depression Scale;; HPA = hypothalamic-pituitary-adrenal;; L1 = lumbar vertebra 1;; L4 = lumbar vertebra 4;; OGTT = oral glucose tolerance test.
This article has been cited by other articles:
![]() |
M. V Schmidt, C. Liebl, V. Sterlemann, K. Ganea, J. Hartmann, D. Harbich, S. Alam, and M. B Muller Neuropeptide Y mediates the initial hypothalamic-pituitary-adrenal response to maternal separation in the neonatal mouse J. Endocrinol., May 1, 2008; 197(2): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hach, U. E. Ruhl, M. Klose, J. Klotsche, W. Kirch, and F. Jacobi Obesity and the risk for mental disorders in a representative German adult sample Eur J Public Health, June 1, 2007; 17(3): 297 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vogelzangs, A. T. F. Beekman, S. B. Kritchevsky, A. B. Newman, M. Pahor, K. Yaffe, S. M. Rubin, T. B. Harris, S. Satterfield, E. M. Simonsick, et al. Psychosocial Risk Factors and the Metabolic Syndrome in Elderly Persons: Findings From the Health, Aging and Body Composition Study J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2007; 62(5): 563 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Kroenke, G. G. Bennett, C. Fuchs, E. Giovannucci, I. Kawachi, E. Schernhammer, M. D. Holmes, and L. D. Kubzansky Depressive Symptoms and Prospective Incidence of Colorectal Cancer in Women Am. J. Epidemiol., November 1, 2005; 162(9): 839 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Kahl, M. Bester, W. Greggersen, S. Rudolf, L. Dibbelt, B. M. Stoeckelhuber, H.-B. Gehl, V. Sipos, F. Hohagen, and U. Schweiger Visceral Fat Deposition and Insulin Sensitivity in Depressed Women With and Without Comorbid Borderline Personality Disorder Psychosom Med, May 1, 2005; 67(3): 407 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rozanski, J. A. Blumenthal, K. W. Davidson, P. G. Saab, and L. Kubzansky The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology J. Am. Coll. Cardiol., March 1, 2005; 45(5): 637 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fisher, G. Laurencin, C. A. Chesla, M. M. Skaff, J. T. Mullan, P. S. Gardiner, and K. M. Chun Depressive Affect Among Four Ethnic Groups of Male Patients With Type 2 Diabetes Diabetes Spectr, October 1, 2004; 17(4): 215 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Perras, B. Schultes, B. Behn, C. Dodt, J. Born, and H. L. Fehm Intranasal Atrial Natriuretic Peptide Acts as Central Nervous Inhibitor of the Hypothalamo-Pituitary-Adrenal Stress System in Humans J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4642 - 4648. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D Sammel, J. A. Grisso, E. W Freeman, L. Hollander, L. Liu, S. Liu, D. B Nelson, and M. Battistini Weight gain among women in the late reproductive years Fam. Pract., August 1, 2003; 20(4): 401 - 409. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |